Gastric cancer (GC) is defined as the primary epithelial malignancy derived from the
stomach, and it is a complicated and heterogeneous disease with multiple risk factors …

The overall burden of cancer is rapidly increasing worldwide, reflecting not only population
growth and aging, but also the prevalence and spread of risk factors. Gastrointestinal (GI) …

DLD is a key gene involved in “cuproptosis,” but its roles in tumor progression and immunity
remain unclear. Exploring the potential mechanisms and biological roles of DLD may …

Pyroptosis is a type of inflammatory cell death that is triggered by the formation of pores on
the cell membrane by gasdermin (GSDM) family proteins. This process activates …

Cancer immunotherapy, a therapeutic approach that inhibits tumors by activating or
strengthening anti-tumor immunity, is currently an important clinical strategy for cancer …

Antibody–drug conjugates (ADCs) are a potential and promising therapy for a wide variety of
cancers, including breast cancer. ADC-based drugs represent a rapidly growing field of …

In the past decade, the Chinese government has committed to promoting gastric cancer
(GC) prevention and control 1, 2. GC is a major malignancy globally, and nearly half of GC …

Objective To explore the return-to-work adaptation experience and coping resources used
by cancer patients. Methods With the help of the Nantong Cancer Friends Association, from …

Glioblastomas (GBMs) are the brain tumors with the highest malignancy and poorest
prognoses. GBM is characterized by high heterogeneity and resistance to drug treatment …

Objective: Epidermal growth factor receptor variant III (EGFRvIII) is a constitutively-activated
mutation of EGFR that contributes to the malignant progression of glioblastoma multiforme …